Canada - English - Health Canada

wn pharmaceuticals ltd. - vitamin a (vitamin a acetate); vitamin e (dl-alpha tocopheryl acetate); ascorbic acid (ascorbic acid, sodium ascorbate); folic acid; vitamin b1 (thiamine mononitrate); vitamin b2 (riboflavin); nicotinamide; vitamin b6 (pyridoxine hydrochloride); vitamin b12 (cyanocobalamin); vitamin d3; biotin; d-pantothenic acid (calcium d-pantothenate); calcium (calcium carbonate); iodine (potassium iodide); iron (ferrous fumarate); copper (cupric oxide) - tablet - 5000unit; 10unit; 75mg; 0.1mg; 1.6mg; 1.8mg; 20mg; 2mg; 4mcg; 400unit; 30mcg; 10mg; 162mg; 0.15mg; 5mg; 1mg - vitamin a (vitamin a acetate) 5000unit; vitamin e (dl-alpha tocopheryl acetate) 10unit; ascorbic acid (ascorbic acid, sodium ascorbate) 75mg; folic acid 0.1mg; vitamin b1 (thiamine mononitrate) 1.6mg; vitamin b2 (riboflavin) 1.8mg; nicotinamide 20mg; vitamin b6 (pyridoxine hydrochloride) 2mg; vitamin b12 (cyanocobalamin) 4mcg; vitamin d3 400unit; biotin 30mcg; d-pantothenic acid (calcium d-pantothenate) 10mg; calcium (calcium carbonate) 162mg; iodine (potassium iodide) 0.15mg; iron (ferrous fumarate) 5mg; copper (cupric oxide) 1mg - vitamins & minerals

Canada - English - Health Canada

pharmetics (2011) inc - copper (cupric sulfate); manganese (manganese sulfate); tin (stannous chloride); zinc (zinc oxide); iodine (potassium iodide); nickel (nickel sulfate); potassium (potassium chloride); chlorine (potassium chloride); chromium (chromic chloride); selenium (sodium selenite); molybdenum (sodium molybdate); vanadium (sodium metavanadate); silicon (silicon dioxide, sodium metasilicate); vitamin a (vitamin a acetate); beta-carotene; vitamin e (dl-alpha tocopheryl acetate); ascorbic acid (ascorbic acid); folic acid; vitamin b1 (thiamine mononitrate); vitamin b2 (riboflavin); nicotinamide; vitamin b6 (pyridoxine hydrochloride); vitamin b12 (cyanocobalamin); vitamin d3 (cholecalciferol); biotin; d-pantothenic acid (calcium d-pantothenate); calcium (calcium phosphate); phosphorus (calcium phosphate); iron (ferrous fumarate); magnesium (magnesium oxide) - tablet - 2mg; 4mg; 0.010mg; 15mg; 0.150mg; 5mcg; 80mg; 72mg; 120mcg; 70mcg; 50mcg; 10mcg; 4mg; 4000unit; 1000unit; 60unit; 120mg; 0.4mg; 4.5mg; 5.1mg; 40mg; 6mg; 18mcg; 400unit; 40mcg; 10mg; 162mg; 125mg; 15mg; 50mg - copper (cupric sulfate) 2mg; manganese (manganese sulfate) 4mg; tin (stannous chloride) 0.010mg; zinc (zinc oxide) 15mg; iodine (potassium iodide) 0.150mg; nickel (nickel sulfate) 5mcg; potassium (potassium chloride) 80mg; chlorine (potassium chloride) 72mg; chromium (chromic chloride) 120mcg; selenium (sodium selenite) 70mcg; molybdenum (sodium molybdate) 50mcg; vanadium (sodium metavanadate) 10mcg; silicon (silicon dioxide, sodium metasilicate) 4mg; vitamin a (vitamin a acetate) 4000unit; beta-carotene 1000unit; vitamin e (dl-alpha tocopheryl acetate) 60unit; ascorbic acid (ascorbic acid) 120mg; folic acid 0.4mg; vitamin b1 (thiamine mononitrate) 4.5mg; vitamin b2 (riboflavin) 5.1mg; nicotinamide 40mg; vitamin b6 (pyridoxine hydrochloride) 6mg; vitamin b12 (cyanocobalamin) 18mcg; vitamin d3 (cholecalciferol) 400unit; biotin 40mcg; d-pantothenic acid (calcium d-pantothenate) 10mg; calcium (calcium phosphate) 162mg; phosphorus (calcium phosphate) 125mg; iron (ferrous fumarate) 15mg; magnesium (magnesium oxide) 50mg - vitamins & minerals

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 100 mg/ml; riboflavine sodium phosphate, quantity: 2 mg/ml; nicotinamide, quantity: 20 mg/ml; dexpanthenol, quantity: 20 mg/ml; pyridoxine hydrochloride, quantity: 40 mg/ml; cyanocobalamin, quantity: 0.4 mg/ml - injection, solution - excipient ingredients: disodium edetate; benzyl alcohol; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7. carpal tunnel syndrome. 8. pernicious anaemia as a result of in situ b12 deficiency. general indications include: 1. angular stomatitis and glossitis have been shown in some instances to respond to t

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - riboflavine sodium phosphate, quantity: 5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 25 mg/ml; pyridoxine hydrochloride, quantity: 50 mg/ml; cyanocobalamin, quantity: 250 microgram/ml - injection, solution - excipient ingredients: disodium edetate; water for injections; benzyl alcohol - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. note: b-dose plus 2ml injection does not contain thiamine. 5. peripheral neuritis caused by various b group de

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - riboflavine sodium phosphate, quantity: 5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 25 mg/ml; pyridoxine hydrochloride, quantity: 50 mg/ml; cyanocobalamin, quantity: 250 microgram/ml - injection, solution - excipient ingredients: disodium edetate; water for injections; benzyl alcohol - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. note: b-dose plus 2ml injection does not contain thiamine. 5. peripheral neuritis caused by various b group de

Bangladesh - English - DGDA (Directorate General of Drug Administration)

ethical drug ltd. - cyanocobalamin + dl-methionine + inositol + nicotinamide + pantothenic acid + pyridoxine hydrochloride + riboflavin + vitamin b1 - injection - 2 mcg + 5 mg + 2 mg + 100 mg + 10 mg + 5 mg + 5 mg + 50 mg/ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

healol pharmaceuticals sdn. bhd. - cyanocobalamin; lecithin; nicotinamide; pyridoxine hydrochloride; riboflavin; thiamine mononitrate; dl-alpha tocopheryl acetate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid pharmacy sdn. bhd. - cyanocobalamin; nicotinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; dl-alpha tocopheryl acetate; lecithin soya bean -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kotra pharma (m) sdn. bhd. - vitamin a; vitamin d3 (cholecalciferol); vitamin e; thiamine hydrochloride; pyridoxine hydrochloride; nicotinamide; vitamin b12 (cyanocobalamin); ascorbic acid (vitamin c); d-panthenol; l-lysine hydrochloride; riboflavin 5-phosphate sodium -

Bangladesh - English - DGDA (Directorate General of Drug Administration)

albion laboratories ltd. - cyanocobalamin + dl-methionine + inositol + nicotinamide + pantothenic acid + pyridoxine hydrochloride + riboflavin + vitamin b1 - injection - 2 mcg + 5 mg + 2 mg + 100 mg + 10 mg + 5 mg + 5 mg + 50 mg/ml